Conference on Cell & Gene Therapy for HIV Cure 2016

3rd Annual Conference on Cell & Gene Therapy for HIV Cure to be held August 4-5, 2016 in Seattle, WA

WEBSITE
ctg4hivcure2016.org

DATES
Pre-Conference Community Event: August 3, 2016
Conference: August 4-5, 2016

LOCATION
Fred Hutchinson Cancer Research Center
Seattle, WA USA

We are pleased to announce the 3rd Conference on Cell & Gene Therapy for HIV Cure will be held August 4-5, 2016 in Seattle, WA. This conference aims to bring much needed attention to HIV cell and gene therapies by uniting an international roster of esteemed scientists to share and discuss novel treatments and research using these innovative modalities.

Featured speakers include:

KEYNOTE
Lawrence Corey, MD
President and Director Emeritus
Fred Hutchinson Cancer Research Center
Lawrence Corey Endowed Chair in Medical Virology
Professor, Laboratory Medicine and Allergy and Infectious Diseases
University of Washington

PLENARIES
Warner C. Greene, MD, PhD
Direcot, Senior Investigator
Gladstone Institute of Virology and Immunology
Nick and Sue Hellmann Distinguished Professor of Translational Medicine
Professor of Medicine, Microbiology and Immunology
University of California, San Francisco

Timothy Henrich, MD
Assistant Professor, Department of Medicine
Division of Experimental Medicine
University of California, San Francisco

Mark Kay, MD, PhD
Dennis Farrey Family Professor
Department of Pediatrics and Genetics
Vice Chair for Basic Research (Pediatrics)
Stanford University

 

This two-day international conference will be held at the campus of Fred Hutchinson Cancer Research Center in Seattle, WA. A pre-conference Community Event, organized by the defeatHIV Community Advisory Board, will be held the evening of August 3, 2016.

We look forward to building on the success of the first two conferences, held in 2014 and 2015, and invite HIV and cell and gene therapy researchers, clinicians, young investigators and trainees including pre- and post-doctoral fellows, to participate. Scholarships are available to trainees. We also continue to partner with community advocates, including HIV community advisory board (CAB) members, and are pleased to offer a limited number of community sponsorship and volunteer opportunities.

Please visit our conference website for more details!

CGT4HIVCure2016.org

Conference on Cell and Gene Therapy for HIV Cure 2015

WEBSITE
ctg4hivcure2015.org

DATES
August 13-14, 2015

LOCATION
Fred Hutchinson Cancer Research Center
Seattle, WA USA

 

We are pleased to announce the 2nd Conference on Cell & Gene Therapy for HIV Cure will be held August 13-14, 2015, in Seattle, WA. This conference aims to bring much needed attention to HIV cell and gene therapies by uniting an international roster of esteemed scientists to share and discuss novel treatments and research using these innovative modalities.

Featured speakers include:

KEYNOTE
David Baltimore, PhD
President Emeritus
Robert Andrews Millikan Professor of Biology
California Institute of Technology
Nobel Prize in Physiology or Medicine (1975)
National Medal of Science (1999)

PLENARIES
Dan H Barouch, MD, PhD
Professor of Medicine
Harvard Medical School
Director, Center for Virology and Vaccine Research
Beth Israel Deaconess Medical Center

Michael Farzan, PhD
Vice Chairman
Professor, Department of Immunology and Microbial Science
Scripps Research Institute

Matthew Porteus, MD, PhD
Associate Professor, Pediatrics – Stem Cell Transplantation
Member – Bio-X, Child Health Research Institute, Stanford Cancer Institute
Stanford University

This two-day international conference will be held at the campus of Fred Hutchinson Cancer Research Center in Seattle, WA. The audience will consist of national and international scientific researchers, early investigators, post docs, and graduate students. Registration Scholarships and Travel Grants are available.

Please visit our conference website for more details!

CGT4HIVCure2015.org

 

defeatHIV CAB: Meeting March 2014

defeatHIVCAB meetings March-June 2014_flyer

defeatHIV CAB Meeting

Tuesday March 4, 2014  |  5:30-7:30 PM

Cal Anderson House

400 Broadway
Seattle, WA 98112

RSVP TO:  206-667-5810 or mlouella@fhcrc.org

The defeatHIV Community Advisory Board (CAB) invites you to join us on Tuesday, March 4th at our next monthly CAB meeting.

Agenda items include planning for our upcoming event, A Community Q&A on HIV Cure with Bob Siliciano, and building our CAB governance/work plan, among others. 

Please RSVP and join us!

defeatHIV Events: The Word on an HIV Cure

WORD CURE FINAL thumb 3    WORD CURE FINAL thumb 2    WORD CURE FINAL thumb 1b

 

THE WORD ON AN HIV CURE

Tuesday, January 14, 2104
7 to 8:30 PM

MIller Community Center
330 19th Avenue East
(intersection of Thomas and 19th Ave)
Seattle, WA 98112

FOR MORE INFO: 206-667-5810

Facebook Event Page:  THE WORD ON AN HIV CURE in Seattle

The defeatHIV Community Advisory Board (CAB) invites you to join us on Tuesday, January 14th at our next community event; “THE WORD ON AN HIV CURE.”

This evening will be a great way to meet defeatHIV, the scientists & the community members who have come together to support the research into an HIV cure conducted in Seattle at Fred Hutchinson Cancer Research Center.

The event is free, no registration required.  We will have free food and some entertainment to start us of on a good foot.

The two men who lead defeatHIV, Drs. Hans-Peter Kiem and Keith Jerome, will be on hand to reveal their current research and answer your questions on how they plan to create HIV-resistant cells and to ‘snip’ HIV DNA from its hiding places throughout the body.

This research attempts to build on the unique case of Timothy Ray Brown, the first person to be cured of HIV, but to make his HIV cure accessible to many more people using some nontraditional methods.

In addition, we will begin a community conversation around HIV cure research and the necessary roles that only community members could fulfill, which promises to be a discussion you will want to listen to, if not add your own voice to the mix.

What is there for me to talk about in HIV cure research
Some—and by no means all– of the questions we will want to hear your thoughts on during our discussion:

  • How much risk is too much? Some studies offer no chance for direct medical benefit (proof of concept). Others have higher risks.
  • Where do we draw the line in terms of too much risk?
  • How do we accurately speak about cure? Basic concepts are difficult to describe in plain language
  • What does ‘cured’ mean to you, and how can we know it? Proving someone is “cured” could be quite difficult – need for very long follow-up
  • What role does altruism play in deciding to join a cure research study? Some studies must be done in very healthy HIV-positive people
  • Should we even use the word ‘cure’? Recruitment must be ethical and must not overemphasize benefits (even inadvertently). Use the “c”word carefully.
  • At what cost?  A cure could be quite expensive
  • Will anyone be left out? What can we do to ensure this isn’t a future reality? A cure might only work for some people
  • How do we begin to dismantle the media hype or years of myths and false beliefs around a cure for HIV?
  • What effect does hearing about HIV cure research have on decisions around preventing HIV infection?
  • Outside of clinical trials, how else might I get involved?

If we are ever to see a cure for HIV achieved in our lifetimes, we will need every one of us to play a part.

As a group of people from various communities around Seattle, we have gathered to support this local work towards a cure. We are convinced that community voices as educators and advocates are needed now at the start of this journey to ensure that whatever cure may come is accessible to everyone.

Please join us on this journey.

We look forward to seeing you on January 14th.

From One To Many

The Cure Agenda for HIV/AIDS at Fred HutchFrom One to Many

In Collaboration with defeatHIV

Scientific Forum

Tuesday, June 18, 2013 | 11am–4pm
“HIV Cure Research in Seattle – the Underlying Science and Clinical Studies”
Fred Hutchinson Cancer Research Center, Seattle, WA

Community Event

Wednesday, June 19, 2013 | 6pm–8:30pm
Timothy Brown Panel Discussion Moderated by Margaret Larson of Seattle’s King 5 News
Seattle University, Seattle, WA

Timothy Ray Brown (“The Berlin Patient”) is thought to be the only individual functionally cured of HIV. Through a combination of chemotherapy followed by transplantation of HIV-resistant hematopoietic cells, his clinicians provided an important proof of concept that the latent reservoirs of HIV can be eradicated using nontraditional methods. Now six years after his transplant, Timothy remains free of both his cancer and readily detectable HIV. On behalf of the HIV-affected community, he currently serves as an advocate for HIV cure efforts performed by researchers and clinicians across the globe.


Scientific Forum

Fred Hutchinson Cancer Research Center, Seattle, WA
Tuesday June 18, 2013
11am-4pm PDT / 2pm-7pm EDT / 6pm-11pm GMT
View live video stream: http://stream.fhcrc.org/defeatHIV_061813

Timothy will be visiting the Fred Hutchinson Cancer Research Center in Seattle on June 18 to highlight the work of the defeatHIV Martin Delaney Collaboratory, which is working on an HIV cure therapy that closely mirrors Timothy’s unique and successful treatment. As a highlight of Timothy’s visit, defeatHIV will host a scientific meeting at the Fred Hutch to present the current state of defeatHIV’s cure efforts – “HIV Cure Research in Seattle – the Underlying Science and Clinical Studies.”

The HIV Cure Forum will present scientific data from defeatHIV researchers and industry partners on the collaboratory’s progress to date, specifically how progress in the lab is being translated into clinical studies. Timothy will speak about his personal experience as the first person to be functionally cured, as well as other HIV investigators actively involved in HIV cure efforts.

Questions? Send inquiries to info@defeatHIV.org.


Community Event

Seattle University, Seattle, WA
Wednesday June 19, 2013
6pm-7pm PDT Social Hour
7-8:30pm PDT Moderated Panel Discussion and Open Q&A
Attend in person – the event is free and open to the public, no RSVP required!

Margaret Larson of Seattle’s King 5 news will moderate a panel discussion with Timothy Ray Brown, Fred Hutch defeatHIV researchers Drs. Keith Jerome, Hans-Peter Kiem, and Michele Andrasik. Julie McElrath, director of Fred Hutch’s Vaccine and Infectious Disease Division, will kick off the discussion with a brief introduction.

Whether you are a provider referring patients, a participant volunteering for a study, or a member of the community interested in learning about/getting involved with our research into a cure—please join us to better understand how each of us might help to make one man’s HIV cure a reality for the millions of people living with HIV!

Questions? externalrel@fhcrc.org | 206-667-4241 | www.fhcrc.org/fromonetomany

Social Media

  • Follow @HutchinsonCtr for a live Twitter stream
  • Contribute to the discussion on Twitter at #defeatHIV
  • Join the Facebook event for June 19th

Facilities provided by:
Seattle University


In collaboration with defeatHIV institutions:
Fred Hutchinson Cancer Research Center
University of Washington
Seattle Children’s Research Institute
Beckman Research Institute of City of Hope
Sangamo BioSciences
National Institutes of Health

Both events Sponsored by:
CFAR Curative Therapies for HIV Scientific Working Group
UW/FHCRC CFAR Community Action Board
Pregenen
Sangamo BioSciences

defeatHIV Events: 1st Joint Martin Delaney Collaboratory Meeting

“Strategies for an HIV Cure”
November 28-30, 2012
Washington, D.C.
Sponsored by the Division of AIDS (DAIDS) at the NIAID, NIH

This meeting will bring together researchers associated with each of the three NIH-funded Martin Delaney Collaboratories, other researchers engaged in HIV cure research, investigators in complementary disciplines, and community members to share scientific results and engage in active discussion about the merits of various HIV cure approaches under investigation. (Registration is closed).

For more information, visit the Strategies for an HIV Cure meeting page.

defeatHIV Events: Dr. Richard Harrigan to Speak on Management of HIV Drug Resistance

Dr. Richard Harrigan

Dr. Richard Harrigan

HIV Drug Resistance and the Emerging Role of “Next Generation” DNA Sequencing for Routine Clinical Management of HIV Therapy
Wednesday, October 3, 2012, 3:30pm
Department of Laboratory Medicine Grand Rounds
University of Washington, Health Sciences Bldg, D209

Richard Harrigan, Director, Center for Excellence in HIV/AIDS, University of British Columbia

Dr. Richard Harrigan is the Director of Research Laboratories at the BC Centre for Excellence in HIV/AIDS. His work primarily focuses on HIV drug efficacy, drug resistance, and the human and viral parameters that influence HIV disease progression. At the BC Centre for Excellence in HIV/AIDS, his work has involved investigations using three major cohort studies, as well as the more than five thousand patients in the BC Drug Treatment Program.

Before working at the CfE, Dr. Harrigan was at the pharmaceutical companies Wellcome and Glaxo Wellcome in the United Kingdom. Dr. Harrigan was also one of the first to demonstrate the potential clinical utility of HIV drug resistance testing and introduced one of the world’s first broadly based clinical HIV drug resistance testing programs; this program has tested more than 50,000 clinical samples from across Canada. Dr Harrigan is currently investigating the application of newer “deep-sequencing” technologies in the clinical management of HIV therapies.

Dr. Harrigan holds the Glen-Hillson Professorship in Clinical HIV Virology and the CIHR-GSK Research Chair in HIV/AIDS at the University of British Columbia, and is an Associate Professor in the Division of AIDS (Faculty of Medicine) at the University of British Columbia.

defeatHIV Events: 2012 defeatHIV Annual Meeting

2012 defeatHIV Annual Meeting2012 defeatHIV Annual Meeting

On May 31, 2012 the defeatHIV Martin Delaney Collaboratory held its first Annual Meeting at the Fred Hutchinson Cancer Research Center in Seattle, WA. defeatHIV investigators from the Hutchinson Center, University of Washington, Seattle Children’s Hospital, City of Hope, Sangamo BioSciences and NIH participated in what was a productive review of the collaboratory’s operational and scientific accomplishments in our first year of funding.

Also taking part were members of the defeatHIV Scientific Advisory Panel, whose comments and feedback on Year 1 progress will provide further refinement of our approaches and facilitate achievement of our milestones.

Look for more details on our progress in Year 1, and goals for Year 2, in the defeatHIV Newsletter arriving soon! Subscribe here.